Azilsartan Medoxomil API Market

Azilsartan medoxomil (trade name Edarb) is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is indicated for the treatment of hypertension to lower blood pressure which reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Azilsartan medoxomil may be used either alone or in combination with other antihypertensive agents such as chlorthalidone (CLD). As an ARB, azilsartan medoxomil selectively inhibits angiotensin II from binding to the angiotensin II type-1 receptor (AT1). This receptor inhibition provides the antihypertensive activity of azilsartan medoxomil because it blocks the pressor effects of angiotensin II. Azilsartan medoxomil is a prodrug of azilsartan. It is hydrolyzed to the active moiety, azilsartan, in the gastrointestinal (GI) tract during the absorption phase.
Azilsartan Medoxomil API Market aims to provide a comprehensive presentation of the global market for Azilsartan Medoxomil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azilsartan Medoxomil API. Azilsartan Medoxomil API Market contains market size and forecasts of Azilsartan Medoxomil API in global, including the following market information:
Global Azilsartan Medoxomil API Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Azilsartan Medoxomil API Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Azilsartan Medoxomil API companies in 2022 (%)
The global Azilsartan Medoxomil API market was valued at US$ 15 million in 2022 and is projected to reach US$ 53 million by 2029, at a CAGR of 19.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Main manufacturers of global azilsartan medoxomil API market are Takeda, Metrochem API and Jubilant Pharma. Takeda and Metrochem API are the top 2 players and accounts for over 40% of global market share in total. Geographically speaking, USA is the largest market and covers about 30% of total market share, followed by Europe with 20%. In terms of application, 40 mg Tablets holds an important market share of over 50%.
We surveyed the Azilsartan Medoxomil API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Azilsartan Medoxomil API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Azilsartan Medoxomil API Market Segment Percentages, by Type, 2022 (%)
0.99
Others
Global Azilsartan Medoxomil API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Azilsartan Medoxomil API Market Segment Percentages, by Application, 2022 (%)
20 mg Tablets
40 mg Tablets
80 mg Tablets
Global Azilsartan Medoxomil API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Azilsartan Medoxomil API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Azilsartan Medoxomil API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Azilsartan Medoxomil API revenues share in global market, 2022 (%)
Key companies Azilsartan Medoxomil API sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Azilsartan Medoxomil API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Lupin
Acura Labs
Metrochem API
Jubilant Pharma
Zhejiang Hongyuan
Honour Lab
HEC Pharm
Enomark
CTX Life Sciences
Zhejiang Tianyu
Zhuhai Rundu
Valiant Co
Outline of Major Chapters:
Chapter 1: Introduces the definition of Azilsartan Medoxomil API, market overview.
Chapter 2: Global Azilsartan Medoxomil API market size in revenue and volume.
Chapter 3: Detailed analysis of Azilsartan Medoxomil API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Azilsartan Medoxomil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Azilsartan Medoxomil API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.